28 May 2020
Query Regarding Trading Activity
|Announcement Title||Query Regarding Trading Activity|
|Date & Time of Broadcast||May 28, 2020 9:32|
|Submitted By (Co./ Ind. Name)||SINGAPORE EXCHANGE REGULATION PTE. LTD.|
|Query Description (Please provide a detailed description of the Query in the box below)||28 May 2020
UG Healthcare Corporation Limited
QUERY REGARDING TRADING ACTIVITY
We have noted, and draw to your attention, unusual price movements in your shares recently. To maintain a fair, orderly and transparent market, please answer each of the following:
Question 1: Are you (the issuer) aware of any information not previously announced concerning you, your subsidiaries or associated companies which, if known, might explain the trading? Such information may include events that are potentially material and price-sensitive, such as discussions and negotiations that may lead to joint ventures, mergers, acquisitions or purchase or sale of a significant asset. You may refer to paragraph 9 in Appendix 7A of the Catalist Rules for further examples.
- If yes, the information shall be announced immediately.
Question 2: Are you aware of any other possible explanation for the trading? Such information may include public circulation of information by rumours or reports.
Question 3: Can you confirm your compliance with the listing rules and, in particular, Catalist Rule 703?
The Board of Directors shall collectively and individually take responsibility for the accuracy of the reply to the query. Please also refer to Practice Note 7A of the Catalist Rules for guidelines to deal with particular situations and issues. This may include the issuance of a holding announcement, if necessary.
Please respond immediately via SGXNet. Where appropriate, you may want to request a trading halt or a suspension of trading. Please contact Securities Market Control (or, if you need to discuss the matter, your sponsor) immediately. Thank you for your cooperation.
We have released this letter via SGXNet.
Head of Surveillance
1. An issuer must announce any information known to the issuer concerning it or any of its subsidiaries or associated companies which is necessary to avoid the establishment of a false market in the issuer s securities, or would be likely to materially affect the price or value of its securities (Rule 703).
2. An issuer must undertake a review to determine the causes of any unusual trading activity (paragraph 22 of Appendix 7A).
3. An announcement should, among other things, state whether the issuer or any of its directors are aware of the reasons for the unusual trading activity and whether there is any material information which has not been publicly disclosed (paragraph 33 of Appendix 7A).
4. Your responsibility under listing rules is not confined to, or necessarily satisfied by, answering the questions in this letter.